Syed Mohammed A, Yang Zhi, Hu Xiaoping P, Deshpande Gopikrishna
Computer Science and Software Engineering Department, Auburn UniversityAuburn, AL, United States.
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of MedicineShanghai, China.
Front Neurosci. 2017 Sep 8;11:459. doi: 10.3389/fnins.2017.00459. eCollection 2017.
Autism is a developmental disorder that is currently diagnosed using behavioral tests which can be subjective. Consequently, objective non-invasive imaging biomarkers of Autism are being actively researched. The common theme emerging from previous functional magnetic resonance imaging (fMRI) studies is that Autism is characterized by alterations of fMRI-derived functional connections in certain brain networks which may provide a biomarker for objective diagnosis. However, identification of individuals with Autism solely based on these measures has not been reliable, especially when larger sample sizes are taken into consideration. We surmise that metrics derived from Autism subjects may not be highly reproducible within this group leading to poor generalizability. We hypothesize that functional brain networks that are most reproducible within Autism and healthy Control groups separately, but not when the two groups are merged, may possess the ability to distinguish effectively between the groups. In this study, we propose a "discover-confirm" scheme based upon the assessment of reproducibility of independent components obtained from resting state fMRI (discover) followed by a clustering analysis of these components to evaluate their ability to discriminate between groups in an unsupervised way (confirm). We obtained cluster purity ranging from 0.695 to 0.971 in a data set of 799 subjects acquired from multiple sites, depending on how reproducible the corresponding components were in each group. The proposed method was able to characterize reproducibility of brain networks in Autism and could potentially be deployed in other mental disorders as well.
自闭症是一种发育障碍,目前通过行为测试进行诊断,而这些测试可能具有主观性。因此,人们正在积极研究自闭症的客观非侵入性成像生物标志物。以往功能磁共振成像(fMRI)研究中出现的一个共同主题是,自闭症的特征是某些脑网络中fMRI衍生的功能连接发生改变,这可能为客观诊断提供生物标志物。然而,仅基于这些测量来识别自闭症患者并不可靠,尤其是考虑到更大的样本量时。我们推测,来自自闭症患者的指标在该群体中可能无法高度重现,导致可推广性较差。我们假设,在自闭症组和健康对照组中分别具有最高重现性,但两组合并时则不然的功能性脑网络,可能具有有效区分两组的能力。在本研究中,我们提出了一种“发现-确认”方案,该方案基于对静息态fMRI获得的独立成分的重现性评估(发现),然后对这些成分进行聚类分析,以无监督的方式评估它们区分组别的能力(确认)。在从多个地点采集的799名受试者的数据集中,根据相应成分在每组中的重现程度,我们获得的聚类纯度在0.695至0.971之间。所提出的方法能够表征自闭症患者脑网络的重现性,并且也有可能应用于其他精神障碍。